Journal of Human Genetics and Genomics

Published by: Kowsar

Evaluation of Expression Levels of Linc-ROR and HULC Genes in Breast Cancer Cells (MCF7) Following Treatment with Nanocurcumin

Mahboobe Seyed Hosseyni 1 , Amirali Gholamin 1 , Fateme Roohollah 2 and Majid Sadeghizadeh 3 , *
Authors Information
1 Department of Molecular Genetics, Faculty of Advance Sciences and Technology, Medical Sciences Branch, Islamic Azad University, Tehran, Iran
2 Department of Cellular and Molecular Biology, Faculty of Advance Sciences and Technology, Medical Sciences Branch, Islamic Azad University, Tehran, Iran
3 Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
Article information
  • Journal of Human Genetics and Genomics: 3 (1); e100080
  • Published Online: January 22, 2020
  • Article Type: Research Article
  • Received: December 10, 2019
  • Accepted: January 15, 2020
  • DOI: 10.5812/jhgg.100080

How to Cite: Seyed Hosseyni M , Gholamin A , Roohollah F , Sadeghizadeh M . Evaluation of Expression Levels of Linc-ROR and HULC Genes in Breast Cancer Cells (MCF7) Following Treatment with Nanocurcumin, J Human Gen Genom. Online ahead of Print ; 3(1):e100080. doi: 10.5812/jhgg.100080.

Copyright © 2020, Journal of Human Genetics and Genomics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
3. Methods
4. Results
5. Discussion
  • 1. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41(13):1955-68. doi: 10.1016/j.ejca.2005.05.009. [PubMed: 16081279].
  • 2. National Cancer Institute. Male breast cancer treatment. 2014. Report No.: 2014 Jun 29.
  • 3. World cancer report. World Health Organization; 2014. Report No.: ISBN 92- 832-0429.
  • 4. World cancer report. International Agency for Research on Cancer; 2008.
  • 5. SEER stat fact sheets: Breast cancer. NCI; 2014.
  • 6. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-37. W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. [PubMed: 19920273]. [PubMed Central: PMC2972726].
  • 7. Noori Daloii MR, Yaghubi MM. Apoptosis or programmed cell death and its relation to cancer. Razi J. 1999;11(1):7-27.
  • 8. Levine AJ, Oren M. The first 30 years of p53: Growing ever more complex. Nat Rev Cancer. 2009;9(10):749-58. doi: 10.1038/nrc2723. [PubMed: 19776744]. [PubMed Central: PMC2771725].
  • 9. Vousden KH, Prives C. Blinded by the light: The growing complexity of p53. Cell. 2009;137(3):413-31. doi: 10.1016/j.cell.2009.04.037. [PubMed: 19410540].
  • 10. Yu X, Zheng H, Chan MTV, Wu WKK. HULC: An oncogenic long non‐coding RNA in human cancer. J Cell Mol Med. 2017;21(2):410-7.
  • 11. Peng W, Wu J, Feng J. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016;79:188-93. doi: 10.1016/j.biopha.2016.02.032. [PubMed: 27044827].
  • 12. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847-54. doi: 10.1158/1078-0432.CCR-04-0744. [PubMed: 15501961].
  • 13. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-900. [PubMed: 11712783].
  • 14. Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332-47. doi: 10.2174/138945011794815356. [PubMed: 20955148]. [PubMed Central: PMC3025067].
  • 15. Calabrese V, Bates TE, Mancuso C, Cornelius C, Ventimiglia B, Cambria MT, et al. Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res. 2008;52(9):1062-73. doi: 10.1002/mnfr.200700316. [PubMed: 18792015].
  • 16. Lao CD, Ruffin M, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10. doi: 10.1186/1472-6882-6-10. [PubMed: 16545122]. [PubMed Central: PMC1434783].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments